<DOC>
	<DOCNO>NCT01857843</DOCNO>
	<brief_summary>Objective : To evaluate early effect intensive lipid lower treatment ezetimibe/simvastatin ( Vytorin® ) component coronary plaque . Study Design - Prospective , randomize , single-center study 80 subject enrol - Subjects acute coronary syndrome meet inclusion exclusion criterion enrol . - Eligible subject randomize 1:1 A ) Ezetimibe/Simvastatin ( n=80 ) vs. B ) Pravastatin ( n=80 ) , group patient randomize ratio 1:1 ) ZES ( n=40 ) vs. b ) EES ( n=40 ) , accord type stent use . - All subject undergo VH-IVUS initial procedure . - Follow-up VH-IVUS perform 3 month index procedure . OCT initial procedure 3-months perform available case .</brief_summary>
	<brief_title>Early Effects Intensive Lipid Lowering Treatment With Ezetimibe/ Simvastatin ( Vytorin® ) Assessed Virtual Histology-Intravascular Ultrasound ( VH-IVUS ) Optical Coherence Tomography ( OCT ) Plaque Characteristics Patients With Acute Coronary Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Pravastatin</mesh_term>
	<mesh_term>Ezetimibe</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<mesh_term>Ezetimibe , Simvastatin Drug Combination</mesh_term>
	<criteria>General inclusion criterion 1 . Acute coronary syndrome include unstable angina , acute nonST elevation myocardial infarction acute ST elevation myocardial infarction 2 . Age 20 year old 3 . Patients sign informed consent Angiographic inclusion criterion 1 . De novo lesion without significant plaque ( angiographic lumen diameter stenosis &lt; 50 % ) 2 . Reference vessel diameter ? &gt; 3.0 mm operator assessment 3 . Segment length 1020 mm 4 . Distance PCI site &gt; 5.0mm ( either proximal distal ) 5 . Available serial high quality IVUS study entire segment . 1 . Failed PCI 2 . Recommended coronary artery bypass grafting ( CABG ) 3 . Cardiogenic Shock 4 . Administration lipid lower agent enrollment 5 . Significant hepatic dysfunction ( 3 time normal reference value ) 6 . Significant renal dysfunction ( Serum creatinine &gt; 2.0 mg/dl ) 7 . Significant leukopenia , thrombocytopenia , anemia , know bleed diathesis 8 . Pregnant woman woman potential childbearing 9 . Saphenous vein graft</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
</DOC>